These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 21068471)

  • 21. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
    Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
    Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
    Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
    Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.
    Athyros VG; Bouloukos VI; Pehlivanidis AN; Papageorgiou AA; Dionysopoulou SG; Symeonidis AN; Petridis DI; Kapousouzi MI; Satsoglou EA; Mikhailidis DP;
    Diabetes Obes Metab; 2005 Jul; 7(4):397-405. PubMed ID: 15955126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome: its history, mechanisms, and limitations.
    Oda E
    Acta Diabetol; 2012 Apr; 49(2):89-95. PubMed ID: 21720880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome.
    Maki KC
    Am J Cardiol; 2004 Jun; 93(11A):12C-17C. PubMed ID: 15178512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopause is an independent predictor of metabolic syndrome in Iranian women.
    Eshtiaghi R; Esteghamati A; Nakhjavani M
    Maturitas; 2010 Mar; 65(3):262-6. PubMed ID: 19962253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of metabolic syndrome in Asia.
    Pan WH; Yeh WT; Weng LC
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():37-42. PubMed ID: 18296297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of the metabolic syndrome.
    Grant RW; Meigs JB
    Panminerva Med; 2005 Dec; 47(4):219-28. PubMed ID: 16489321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Bertoni AG; Wong ND; Shea S; Ma S; Liu K; Preethi S; Jacobs DR; Wu C; Saad MF; Szklo M
    Diabetes Care; 2007 Nov; 30(11):2951-6. PubMed ID: 17704348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk.
    Pierdomenico SD; Lapenna D; Di Tommaso R; Di Carlo S; Caldarella MP; Neri M; Mezzetti A; Cuccurullo F
    Am J Hypertens; 2007 Dec; 20(12):1291-6. PubMed ID: 18047919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of the metabolic syndrome in obesity.
    Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Obes Rev; 2005 Nov; 6(4):283-96. PubMed ID: 16246214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and cardiovascular disease.
    Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):84-93. PubMed ID: 16280341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.